Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE) and
a major risk factor for morbidity and mortality. The abundant cell-free nucleic (DNA/RNA) in …

Abstract Programmed death (PD)-1 receptors and their ligands have been identified in the
pathogenesis and development of systemic lupus erythematosus (SLE). Two key pathways …

A proportion of COVID-19 reconvalescent patients develop post-COVID-19 syndrome (PCS)
including a subgroup fulfilling diagnostic criteria of Myalgic encephalomyelitis/Chronic …

Objective: Systemic lupus erythematosus (SLE) is associated to boosted atherosclerosis
development and a higher cardiovascular disease risk. This study aimed to delineate the …

Objective Immune complex (IC) deposition activates polymorphonuclear neutrophils (PMN
s), increases vascular permeability, and leads to organ damage in systemic lupus …

Abstract Pentraxin 3 (PTX3) is a prototypic humoral soluble pattern recognition molecule that
exerts a pivotal role in innate immune response and inflammation, as well as in tissue …

Cardiovascular (CV) morbidity and mortality are a challenge in management of patients with
systemic lupus erythematosus (SLE). Higher risk of CV disease in SLE patients is mostly …

Thrombotic microangiopathies (TMA) constitute a group of different disorders that have a
common underlying mechanism: the endothelial damage. These disorders may exhibit …

Renal microvascular lesions, common in lupus nephritis (LN), are associated with long-term
poor outcomes. There are mainly five pathological types of renal microvascular lesions in …

Systemic lupus erythematosus (SLE) is an idiopathic chronic autoimmune disease that can
affect any organ in the body, including the neurological system. Multiple factors, such as …